GynecologyGynecology2079-56962079-5831Consilium Medicum28597Research ArticleEvaluating the effectiveness of alternative treatments for menopausal symptoms in postmenopausal womenYurenevaS Vsyureneva@gmail.comErmakovaE I-V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation15022017191212609042020Copyright © 2017, Consilium Medicum2017Purpose of the study - to evaluate the effectiveness of black cohosh extract (Chi-Klim drug) and its combination with beta-alanine (Chi-Klim Alanine) for the treatment of menopausal symptoms in women in the early and late postmenopausal women. Materials and methods. A pilot randomized clinical trial included 60 patients aged 40 to 65 years with a duration of menopause not less than 12 months and with a frequency of vasomotor manifestations (tidal) not less than 10 per day. The study did not include women who received menopausal hormone therapy or alternative methods of therapy for the past 3 months. Results. The therapy there was a significant reduction in the severity of menopausal manifestations in both treatment groups, however, in the group 2 the decline was more effective. Acceptance of the drug based on the extract of black cohosh in combination with a dietary supplement on the basis of beta-alanine was 2 times more effective than monotherapy with black cohosh reduced hot flushes per day and had a more pronounced adjoint positive effect on the psycho-emotional symptoms.menopausemenopausal transitionpostmenopauseestrogen deficiencymenopause disordershot flushesplant hormonesменопаузапериод менопаузального переходапостменопаузаэстрогенный дефицитклимактерические расстройстваприливы жарафитогормоны[Schoenaker D.A, Jackson C.A, Rowlands J.V, Mishra G.D. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta - analyses of studies across six continents. Int J Epidemiol 2014; 43: 1542-62.][Сметник В.П. и др. Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста. Климактерий. 2014; 4: 8.][Григорян О.Р., Андреева Е.Н. Менопаузальный синдром у женщин с нарушениями углеводного обмена: научно - практическое руководство. Изд. 2-е, доп. М., 2011; с. 60-9.][Mishra G.D, Dobson A.J. Using longitudinal profiles to characterize women’s symptoms through midlife: results from a large prospective study. Menopause 2012; 19: 549-55.][Gartoulla P, Islam M.R, Bell R.J, Davis S.R. Prevalence of menopausal symptoms in Australian women at midlife: a systematic review. Climacteric 2014; 17: 529-39.][Faubion S.S, Kuhle C.L, Shuster L.T, Rocca W.A. Long - term health consequences of premature or early menopause and considerations for management. Climacteric 2015; 18: 1-9.][Archer D.F, Sturdee D.W, Baber R et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011; 14: 515-28.][Duffy O.K, Iversen L, Aucott L, Hannaford P.C. Factors associated with resilience or vulnerability to hot flushes and night sweats during the menopausal transition. Menopause 2013; 20: 383-92.][Freeman E.W, Sammel M.D, Sanders R.J. Risk of long - term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause 2014; 21 (4): 339-46.][Thurston R.C, Sutton-Tyrrell K, Everson-Rose S et al. Hot flashes and subclinical disease: findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 2008; 118: 1234-40.][Lambrinoudaki I, Augoulea A, Armeni E et al. Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women. Climacteric 2012; 15: 350-7.][Thurston R.C, Chang Y, Mancuso P, Matthews K.A. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women’s Health Across the Nation. Fertil Steril 2013; 100: 793-800.][Lee S.W, Jo H.H, Kim M.R et al. Association between menopausal symptoms and metabolic syndrome in postmenopausal women. Arch Gynecol Obstet 2012; 285: 541-8.][Herber-Gast Gerrie-Cor M, Mishra G.D. Early severe vasomotor menopausal symptoms are associated with diabetes. Menopause 2014; 21 (8): 855-60.][Santen R.J, Allred D.C, Ardoin S.P et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010; 95 (Suppl. 1): 1-66.][The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause 2012; 19 (3): 257-71.][De Villiers T.J, Gass M.L, Haines C.J et al. Global Consensus Statement on menopausal hormone therapy. Climacteric 2013; 16: 203-4.][Leach M.J, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews 2012; Issue 9. Art. No.: CD007244.][Рафаэлян И.В., Балан В.Е., Ковалева Л.А. Эффективность и безопасность применения экстракта цимицифуги рацемозы в терапии климактерического синдрома в течение года (результаты собственного исследования). Мед. совет. 2014; 7: 54-7.][Nelson H.D, Vesco K.K, Haney E et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta - analysis. JAMA 2006; 295 (17): 2057-71.][Hill C.A, Harris R.C, Kim H.J et al. Influence of beta - alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids 2007; 32 (2): 225-33.]